Topics:
Hematologic Malignancies • Medical Oncology • Myeloma • NCI-CCC Tumor Board Question • Indiana University • Hematology • NCI-CCC Myeloma Tumor Board Question
Which patients with smoldering myeloma do you treat?
Answer from: Medical Oncologist at Academic Institution
Let me address the last comment regarding treatment of high risk smoldering myeloma. IF one thinks that the patient requires treatment for myeloma, why treat with a regimen that is NOT the preferred treatment for myeloma? For example, lenalidomide alone or lenalidomide/dexamethasone. If this were "a...
Sign in or Register to read more
Answer from: Medical Oncologist at Academic Institution
We now have a good understanding of disease heterogeneity in smoldering multiple myeloma. As demonstrated by the Mayo Clinic in 2018 with the "20/2/20" revised risk stratification (bone marrow plasma cells > 20%, M-protein > 2g/dL, and serum free light chain ratio > 20), patients with low r...